A detailed history of Armistice Capital, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,897,653 shares of BCLI stock, worth $15.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,897,653
Previous 7,917,653 12.88%
Holding current value
$15.4 Million
Previous $2.69 Million 41.08%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.22 - $0.42 $224,400 - $428,400
-1,020,000 Reduced 12.88%
6,897,653 $1.59 Million
Q2 2024

Aug 14, 2024

BUY
$0.34 - $0.74 $2.69 Million - $5.86 Million
7,917,653 New
7,917,653 $2.69 Million

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $81.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.